Neuren Pharmaceuticals | NEU - Operating Profit

Stock Price
13.00
Daily Change
0.70 5.69%
Monthly
11.30%
Yearly
49.08%
Q2 Forecast
11.77

Neuren Pharmaceuticals reported AUD17.01M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Clinuvel Pharmaceuticals AUD 13.51M 15.95M Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Genetic Signatures AUD -6.34M 1.67M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025